- Home
- CLDI vs SONM Comparison
CLDI vs SONM Comparison
Compare CLDI & SONM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- SONM
- Stock Information
- Founded
- CLDI 2014
- SONM 1999
- Country
- CLDI United States
- SONM United States
- Employees
- CLDI N/A
- SONM N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- SONM Telecommunications Equipment
- Sector
- CLDI Health Care
- SONM Telecommunications
- Exchange
- CLDI Nasdaq
- SONM Nasdaq
- Market Cap
- CLDI 14.0M
- SONM 12.8M
- IPO Year
- CLDI N/A
- SONM 2019
- Fundamental
- Price
- CLDI $0.48
- SONM $1.48
- Analyst Decision
- CLDI Strong Buy
- SONM
- Analyst Count
- CLDI 2
- SONM 0
- Target Price
- CLDI $15.00
- SONM N/A
- AVG Volume (30 Days)
- CLDI 386.9K
- SONM 490.3K
- Earning Date
- CLDI 05-13-2025
- SONM 05-13-2025
- Dividend Yield
- CLDI N/A
- SONM N/A
- EPS Growth
- CLDI N/A
- SONM N/A
- EPS
- CLDI N/A
- SONM N/A
- Revenue
- CLDI N/A
- SONM $58,298,000.00
- Revenue This Year
- CLDI N/A
- SONM $127.68
- Revenue Next Year
- CLDI N/A
- SONM N/A
- P/E Ratio
- CLDI N/A
- SONM N/A
- Revenue Growth
- CLDI N/A
- SONM N/A
- 52 Week Low
- CLDI $0.35
- SONM $1.03
- 52 Week High
- CLDI $4.90
- SONM $10.70
- Technical
- Relative Strength Index (RSI)
- CLDI 38.44
- SONM 39.84
- Support Level
- CLDI $0.41
- SONM $1.25
- Resistance Level
- CLDI $0.45
- SONM $1.80
- Average True Range (ATR)
- CLDI 0.07
- SONM 0.34
- MACD
- CLDI 0.02
- SONM -0.02
- Stochastic Oscillator
- CLDI 56.57
- SONM 19.74
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About SONM Sonim Technologies Inc.
Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the United States, and to Bell, Rogers, and Telus Mobility in Canada. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.